Prostate cancer is known by the companionship with ATM and miRNA it keeps: Craftsmen of translation have dual behaviour with tailors of life thread

Cell Biochemistry and Function

Volumn 30, Issue 7, 2012, Pages 611-617

  Farooqi, Ammad Ahmad ^a   Naqi, Ali ^d   Qureshi, Muhammad Zahid ^c   Rana, Aamir ^b   Khan, Ammara ^b   Riaz, Asma M ^d   Afzal, Syed Muhammad Faheem ^d   Rasheed, Nabeelah ^d   Bhatti, Shahzad ^d  

^a RASHID LATIF MEDICAL COLLEGE   (Pakistan)

^b NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

^c GC UNIVERSITY   (Pakistan)

^d UNIVERSITY OF LAHORE   (Pakistan)

Author keywords

MiRNA; Oncomirs; Prostate cancer; Signalling cascade; Therapeutic interventions

Indexed keywords

ATM PROTEIN; CISPLATIN; MICRORNA; MICRORNA 143; MICRORNA 15; MICRORNA 16; MICRORNA 182; MICRORNA 23A; MICRORNA 34C; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CARCINOGENESIS; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; RNA INTERFERENCE; RNA PROCESSING; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

CELL CYCLE PROTEINS; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTORS; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 84867027815     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2847     Document Type: Article

References (46)

1. Janas MM, Khaled M, Schubert S, et al. Feed-forward microprocessing and splicing activities at a microRNA-containing intron. PLoS Genet 2011; 7(10): e1002330.
2. Bryant RJ, Pawlowski T, Catto JW, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 2012. doi:10.1038/bjc.2011.595.
3. Gade S, Porzelius C, Faelth M, et al. Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer. BMC Bioinformatics 2011; 12(1): 488.
4. Kosaka N, Iguchi H, Yoshioka Y, Hagiwara K, Takeshita F, Ochiya T. Competitive interactions of cancer cells and normal cells via secretory microRNAs. J Biol Chem 2012; 287(2): 1397-1405.
5. Cabarcas SM, Thomas S, Zhang X, et al. The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres. Genomics 2012; 99(2): 108-117.
6. Kraemer A, Anastasov N, Angermeier M, Winkler K, Atkinson MJ, Moertl S. MicroRNA-mediated processes are essential for the cellular radiation response. Radiat Res 2011; 176(5): 575-586.
7. Östling P, Leivonen SK, Aakula A, et al. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Cancer Res 2011; 71(5): 1956-1967.
8. Poliseno L, Salmena L, Riccardi L, et al. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 2010; 3(117): ra29.
9. Wang M, Hu Y, Amatangelo MD, Stearns ME. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer. Mol Cancer Res 2011a; 9(1): 36-50.
10. Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP. Effects of 1α, 25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer 2011b; 10: 58.
11. Wang Y, Huang JW, Li M, et al. MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Mol Cancer Res 2011c; 9(8): 1100-1111.
12. Wang Y, Yu Y, Tsuyada A, et al. Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene 2011d; 30(12): 1470-1480.
13. Leite KR, Sousa-Canavez JM, Reis ST, et al. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol 2011a; 29(3): 265-269.
14. Leite KR, Tomiyama A, Reis ST, et al. MicroRNA expression profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metastasis. Urol Oncol 2011b. doi: 10.1016/j.urolonc.2011.07.002.
15. Leite KR, Tomiyama A, Reis ST, et al. MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer. J Urol 2011c; 185(3): 1118-1122.
16. Tan G, Shi Y, Wu ZH. MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN. Biochem Biophys Res Commun 2012; 417(1): 546-551.
17. Huang Y, Chuang A, Hao H, et al. Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells. Cell Death Differ 2011a; 18(7): 1220-1230.
18. Huang Y, Chuang AY, Ratovitski EA. Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure. Cell Cycle 2011b; 10(22): 3938-3947.
19. Saleh AD, Savage JE, Cao L, et al. Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. PLoS One 2011; 6(10): e24429.
20. Chen S, Wang H, Ng WL, Curran WJ, Wang Y. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level. Int J Radiat Oncol Biol Phys 2011; 81(5): 1524-1529.
21. Ng WL, Yan D, Zhang X, Mo YY, Wang Y. Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J. DNA Repair (Amst). 2010; 9(11): 1170-1175.
22. Yan D, Ng WL, Zhang X, et al. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 2010; 5(7): e11397.
23. Zhang X, Wan G, Mlotshwa S, et al. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res 2010; 70(18): 7176-7186.
24. Zhang X, Wan G, Berger FG, He X, Lu X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol Cell 2011; 41(4): 371-383.
25. Cannell IG, Kong YW, Johnston SJ, et al. p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci U S A 2010; 107(12): 5375-5380.
26. Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA. ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci U S A 2010; 107(4): 1506-1511.
27. Pothof J, Verkaik NS, van IJcken W, et al. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J 2009; 28(14): 2090-2099.
28. Smirnov DA, Cheung VG. ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs. Am J Hum Genet 2008; 83(2): 243-253.
29. Galluzzi L, Morselli E, Vitale I, et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 2010; 70(5): 1793-1803.
30. Nadiminty N, Tummala R, Lou W, et al. MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells. J Biol Chem 2012; 287(2): 1527-1537.
31. Zaman MS, Chen Y, Deng G, et al. The functional significance of microRNA-145 in prostate cancer. Br J Cancer 2010; 103(2): 256-264.
32. Tsai YS, Lin CS, Chiang SL, Lee CH, Lee KW, Ko YC. Areca nut induces miR-23a and inhibits repair of DNA double-strand breaks by targeting FANCG. Toxicol Sci 2011; 123(2): 480-490.
33. Lin YX, Yu F, Gao N, Sheng JP, Qiu JZ, Hu BC. microRNA-143 protects cells from DNA damage-induced killing by downregulating FHIT expression. Cancer Biother Radiopharm 2011; 26(3): 365-372.
34. Moskwa P, Buffa FM, Pan Y, et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 2011; 41(2): 210-220.
35. Valeri N, Gasparini P, Braconi C, et al. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A 2010; 107(49): 21098-21103.
36. Epis MR, Barker A, Giles KM, Beveridge DJ, Leedman PJ. The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells. J Biol Chem 2011; 286(48): 41442-41454.
37. Hao Y, Gu X, Zhao Y, et al. Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila) 2011; 4(7): 1073-1083.
38. Cao P, Deng Z, Wan M, et al. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol Cancer 2010; 9: 108.
39. Dong Q, Meng P, Wang T, et al. MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS One 2010; 5(4): e10147.
40. Musumeci M, Coppola V, Addario A, et al. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene 2011; 30(41): 4231-4242.
41. Takeshita F, Patrawala L, Osaki M, et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 2010; 18(1): 181-187.
42. Porkka KP, Ogg EL, Saramäki OR, et al. The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers. Genes Chromosomes Cancer 2011; 50(7): 499-509.
43. Bonci D, Coppola V, Musumeci M, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008; 14(11): 1271-1277.
44. Hagman Z, Larne O, Edsjö A, et al. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Int J Cancer 2010; 127(12): 2768-2776.
45. Farooqi AA, Mansoor Q, Ismail M, Bhatti S. Therapeutic effect of epigallocatechin-3-gallate (EGCG) and silibinin on ATM dynamics in prostate cancer cell line LNCaP. World J Oncol 2010; 1(6): 242-246.
46. Ivanov VN, Zhou H, Partridge MA, Hei TK. Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells. Cancer Res 2009; 69(8): 3510-3519.